This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Array Genomics. Active years: 2014-2017.
Company Filing History:
Years Active: 2014-2017
Title: Neil Metters: Innovator in Bladder Cancer Detection
Introduction
Neil Metters is a prominent inventor based in Orsay, France. He has made significant contributions to the field of medical diagnostics, particularly in the detection of bladder cancer. With a total of 2 patents to his name, Metters is recognized for his innovative approaches to improving cancer diagnosis.
Latest Patents
One of Neil Metters' latest patents is a method for the urinary detection of bladder cancer. This invention focuses on the diagnosis of bladder cancer, specifically targeting the detection of transitional type bladder carcinomas in urine samples. The method utilizes a DNA chip designed for this purpose, allowing for the determination of the grade of the detected tumors. This advancement has the potential to enhance early detection and treatment options for patients.
Career Highlights
Neil Metters has established himself as a key figure in the medical research community. His work at Array Genomics has been instrumental in developing innovative diagnostic tools that can significantly impact patient care. His dedication to research and development in the field of oncology has earned him respect among his peers.
Collaborations
Throughout his career, Metters has collaborated with notable professionals in the field, including Olivier Cussenot and François Lozach. These collaborations have further enriched his research and contributed to the advancement of cancer detection technologies.
Conclusion
In summary, Neil Metters is a distinguished inventor whose work in bladder cancer detection is paving the way for improved diagnostic methods. His contributions to medical science are invaluable, and his ongoing research continues to inspire advancements in cancer diagnostics.